AHAPS-functionalized silica nanoparticles do not modulate allergic contact dermatitis in mice

Area of Science:

• Dermatology
• Nanotechnology
• Immunology

Background:

• Allergic contact dermatitis (ACD) is a prevalent skin condition.
• Silica nanoparticles (SiO2-NP) have diverse applications, including skin delivery systems.
• Positively charged SiO2-NP, functionalized with AHAPS, are candidates for skin-based delivery systems.

Purpose of the Study:

• To investigate the effect of topical exposure to positively charged AHAPS-functionalized SiO2-NP on an established mouse model of ACD.
• To assess whether AHAPS-SiO2-NP exacerbate or alter the clinical and histological features of ACD.
• To evaluate potential systemic effects, such as changes in serum IgE levels.

Main Methods:

• An oxazolone-induced ACD model was established in SKH1 mice.
• Mice with ACD were topically treated with AHAPS-SiO2-NP or vehicle for five consecutive days.
• Clinical parameters (TEWL, erythema), histological features (inflammation, epidermal thickness), and serum IgE were analyzed.

Main Results:

• Topical administration of AHAPS-SiO2-NP did not significantly alter clinical signs of ACD, including transepidermal water loss and erythema.
• Histological and morphometric analyses showed no increased inflammation, epidermal thickening, or inflammatory infiltrate in NP-treated mice.
• Serum immunoglobulin E (IgE) levels remained unchanged, indicating no systemic allergic response induction.

Conclusions:

• Positively charged AHAPS-functionalized SiO2-NP do not appear to affect the course of established allergic contact dermatitis in this mouse model.
• These findings suggest a potential safety profile for AHAPS-SiO2-NP in the context of ACD exposure.